Segluromet®(metformin hydrochloride) | Synjardy®(metformin hydrochloride) |
---|---|
Prescription Only | Prescription Only |
Dosage & Administration | |
Administration | |
Dosing | |
Latin Shorthand | |
Financial Assistance | |
Out-Of-Pocket Costs With Copay Card | |
$0. Learn more. | $10. Learn more. |
Annual Cap | |
$583 per fill . Learn more. | $175 per month . Learn more. |
Assistance Expiration | |
12 uses. Learn more. | |
Generics | |
No lower-cost generic available | No lower-cost generic available |
Physician Advisory | |
Adverse Reactions | |
Most common adverse reactions associated with ertugliflozin
(incidence ≥5%) were female genital mycotic infections.
Most common adverse reactions associated with metformin
(incidence ≥5%) were diarrhea, nausea, vomiting, flatulence,
abdominal discomfort, indigestion, asthenia, and headache. . Learn more. | Most common adverse reactions associated with empagliflozin (5% or
greater incidence) were urinary tract infection and female genital mycotic
infections.
Most common adverse reactions associated with metformin (>5%) are
diarrhea, nausea/vomiting, flatulence, abdominal discomfort, indigestion,
asthenia, and headache.. Learn more. |
Mechanism of Actions (MoA) | |
SGLT2 Inhibitors. Learn more. | SGLT2 Inhibitors. Learn more. |
Special Populations | |